Tiemann Investment Advisors, LLC Abb Vie Inc. Transaction History

Tiemann Investment Advisors, LLC

$230 Million
Q3 2024

A detailed history of Tiemann Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tiemann Investment Advisors, LLC holds 10,961 shares of ABBV stock, worth $1.9 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

10,961

Previous 11,136 1.57%

Holding current value

$1.9 Million

Previous $1.91 Million 13.3%

% of portfolio

0.94%

Previous 0.85%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $28,672 - $34,882	-175 Reduced 1.57%	10,961 $2.16 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $19,178 - $21,852	120 Added 1.09%	11,136 $2.03 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $43,344 - $48,815	-315 Reduced 2.78%	11,016 $1.71 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $6,679 - $7,732	50 Added 0.44%	11,331 $1.69 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $23,189 - $28,857	-175 Reduced 1.53%	11,281 $1.52 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $31,235 - $35,972	-216 Reduced 1.85%	11,456 $1.83 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $7,192 - $8,625	-52 Reduced 0.44%	11,672 $1.89 Million
Q3 2022 Nov 15, 2022	SELL	$134.21 - $153.93 $644,208 - $738,864	-4,800 Reduced 29.05%	11,724 $1.57 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $5,504 - $6,998	-40 Reduced 0.24%	16,524 $2.53 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $21,776 - $27,018	-165 Reduced 0.99%	16,564 $2.69 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $8,486 - $10,738	79 Added 0.47%	16,729 $2.27 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $27,238 - $30,919	-256 Reduced 1.51%	16,650 $1.8 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $15,781 - $17,581	-150 Reduced 0.88%	16,906 $1.9 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $126,545 - $139,310	1,237 Added 7.82%	17,056 $1.85 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $94,817 - $128,013	1,178 Added 8.05%	15,819 $1.7 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $23,539 - $27,627	-274 Reduced 1.84%	14,641 $1.28 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $18,929 - $25,330	258 Added 1.76%	14,915 $1.46 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $14,512 - $22,002	-225 Reduced 1.51%	14,657 $1.12 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $18,032 - $22,562	-250 Reduced 1.65%	14,882 $1.32 Million
Q3 2019 Nov 15, 2019	SELL	$62.98 - $75.72 $58,760 - $70,646	-933 Reduced 5.81%	15,132 $1.15 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $26,280 - $33,592	-400 Reduced 2.43%	16,065 $1.17 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $19,929 - $24,578	256 Added 1.58%	16,465 $1.52 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $266 - $296	3 Added 0.02%	16,209 $1.53 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $38,156 - $45,147	-425 Reduced 2.56%	16,206 $1.5 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $29,903 - $40,043	325 Added 1.99%	16,631 $1.57 Million
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $67,170 - $73,657	-750 Reduced 4.4%	16,306 $1.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	17,056	17,056 $1.24 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiemann Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiemann Investment Advisors, LLC with notifications on news.

Account

Tiemann Investment Advisors, LLC Abb Vie Inc. Transaction History